Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,039.00
-8.00 (-0.76%)
At close: Mar 13, 2026
Golden House Market Cap
Golden House has a market cap or net worth of 161.22 million as of March 13, 2026. Its market cap has decreased by -55.54% in one year.
Market Cap
161.22M
Enterprise Value
129.50M
Revenue
46.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,039.00
Market Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 161.22M, an increase of 115.62%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 161.22M | 1.66% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 104.64B |
| Danel (Adir Yeoshua) | 2.61B |
| BrainsWay | 1.66B |
| Kamada | 1.58B |
| Geffen Residence & Renewal | 267.57M |
| Epitomee Medical | 232.03M |
| Matricelf | 137.80M |
| InterCure | 137.14M |